Positron Emission Tomography Imaging of Macrophages in Cancer

Candace C Parker1, Suzanne E Lapi1

  • 1Departments of Chemistry and Radiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Cancers
|April 30, 2021
PubMed

Insights

Imaging tumor-associated macrophages (TAMs) using Positron Emission Tomography (PET) offers valuable insights into cancer biology and treatment response. This review explores the diverse applications of PET imaging for macrophages in oncology.

Area of Science:

  • Oncology
  • Immunology
  • Medical Imaging

Background:

  • Macrophages are crucial immune cells involved in various diseases.
  • Tumor-associated macrophages (TAMs) significantly impact cancer progression, including chemoresistance and immune evasion.
  • Targeting and diagnosing through macrophages present therapeutic and biomarker opportunities.

Purpose of the Study:

  • To review the utility of Positron Emission Tomography (PET) for imaging tumor-associated macrophages (TAMs).
  • To highlight the versatility of macrophage imaging in cancer research and clinical applications.

Main Methods:

  • Review of current literature on PET imaging techniques for TAMs.
  • Analysis of studies demonstrating the application of PET in cancer biology, progression, and therapy response.

Main Results:

  • PET imaging allows for non-invasive visualization and characterization of TAMs within the tumor microenvironment.
  • TAM imaging provides critical data on tumor initiation, growth, and response to therapeutic interventions.
  • The review underscores the potential of PET-based TAM imaging as a diagnostic and prognostic tool.

Conclusions:

  • Positron Emission Tomography (PET) imaging of tumor-associated macrophages (TAMs) is a versatile tool in oncology.
  • TAM imaging offers significant potential for understanding cancer biology and guiding treatment strategies.
  • Further development in PET imaging of TAMs can enhance cancer diagnosis and patient management.